CytoSen Therapeutics Logo (WIPO, 01/23/2019)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark CytoSen Therapeutics was filed as Figurative mark on 01/23/2019 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Circles #Segments or sectors of circles or ellipses #Letters presenting a special form of writing #26.01.01 #Circles with dark surfaces or parts of surfaces #Segments of circles or ellipses (except 26.2.7)
| Trademark form | Figurative mark |
| File reference | 1485758 |
| Countries | 
|
| Base trademark |
No. 88048381,
July 23, 2018
|
| Application date | January 23, 2019 |
| Expiration date | July 6, 2020 |
Trademark owner
Paasheuvelweg 25A
1105 BP Amsterdam
NL
1105 BP Amsterdam
NL
goods and services
05
Pharmaceutical preparations for the treatment of immuno
oncological disorders, cancer, diabetes, respiratory, heart,
neurological and auto immune disorders; stem cells for
medical purposes; living cells for medical use; biological
preparations for the treatment of cancer; therapeutic
pharmaceuticals utilizing neural crest cells for use in the
treatment of cancer, autoimmune disease and infectious
diseases; cell preparations, cellular vaccines and cellular
biologics for the treatment of cancer and infectious
diseases by autologous cell-based immunotherapy
35
Data collection for others for research purposes, namely,
the collection, testing and research of patient molecular
and genomic data
42
Scientific and technological services, namely, scientific
research, design, analysis and testing in the field of
cancer evolution and new cancer therapies using natural
killer cells; industrial research in the field of new
pharmaceutical products and new cancer therapies; medical
and veterinary research services in the nature of the
manipulation of cells within a laboratory or research
facility to enable natural killer cells to be used for
medical or therapeutic purposes; scientific research in the
development of new cancer therapies; scientific research in
human and animal cell therapy; scientific research into
preparations for manipulating and adapting human and animal
cells; consultancy relating to all the aforesaid services;
conducting scientific research and clinical trials for
others relating to the use and the engineering of natural
killer cells and cancer treatment and therapy; medical and
scientific research in the field of cancer treatment and
diagnosis; data collection for others for research purposes,
namely, the collection, testing and research of patient
molecular and genomic data; DNA testing services, namely,
collection and preservation of human and animal DNA for
research purposes
44
Medical testing for diagnostic or treatment purposes in the
field of cancer research; medical diagnostic testing,
monitoring and reporting services; medical evaluation of
immuno oncological disorders, cancer, diabetes, respiratory,
heart, neurological and auto immune disorders; medical
monitoring services; medical diagnostic, prognostic and
theranostic screening and testing services; medical
services, namely, collection and preservation of DNA for
medical purposes; consulting services in the nature of
providing medical information; consulting services in the
field of healthcare and cancer diagnoses; providing health
and healthcare information related to cancer, testing and
screening via a website; genetic testing for medical
purposes; providing information in the field of cancer
prevention, screening, diagnosis and treatment for medical
diagnostic and treatment purposes; providing genetics
assessments in the nature of genetic counseling; genetic
testing for medical diagnostic purposes; genomic testing for
medical diagnostic purposes; gene analysis and sequencing
and DNA analysis and sequencing for medical diagnostic
purposes and veterinary diagnostics purposes; gene analysis
and sequencing and DNA analysis and sequencing for use in
cancer diagnosis and treatment; providing health and
healthcare information related to cancer research via a
website
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 7, 2021 | 2021/24 Gaz | US | RAW: Total Ceasing Effect |
| December 24, 2020 | 2021/1 Gaz | KR | Rejection |
| September 10, 2020 | 2020/37 Gaz | JP | Rejection |
| July 6, 2020 | 2020/28 Gaz | KR | Rejection |
| February 25, 2020 | 2020/9 Gaz | AU | Rejection |
| February 7, 2020 | 2020/7 Gaz | EM | Rejection |
| November 12, 2019 | 2019/50 Gaz | CN | Rejection |
| January 23, 2019 | 2019/34 Gaz | US | Registration |
ID: 141485758